Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Spokes

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|March 1, 1979
Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophreniaA Arregui, A V MacKay, L L Iversen, et al.
Psychological Medicine|May 1, 1980
Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophreniaA Arregui, A V Mackay, E G Spokes, et al.
Clinical Endocrinology|January 1, 1981
Human post-mortem pineal enzyme activityJ A Smith, T J Mee, D J Padwick, et al.
Science (New York, N.Y.)|September 28, 1979
Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatmentN C Bacopoulos, E G Spokes, E D Bird, et al.
Journal of the Neurological Sciences|December 1, 1980
Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjectsE G Spokes, N J Garrett, M N Rossor, et al.
Lancet (London, England)|October 29, 1977
Human post-mortem pineal metabolismJ A Smith, E G Spokes, E D Bird, et al.
European Journal of Clinical Investigation|October 1, 1979
Distribution of beta-endorphin in normal and schizophrenic human brainsS L Lightman, E G Spokes, G A Sagnella, et al.
BMJ (Clinical Research Ed.)|September 15, 1990
Cell implantation in Parkinson's diseaseP Madeley, J L Boyd, C A Biggins, et al.
BMJ (Clinical Research Ed.)|November 30, 1996
Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactionsH H Hamdalla, C H Hawkes, E G Spokes, et al.
Lancet (London, England)|January 21, 1978
Glutamic-acid decarboxylase in schizophreniaE D Bird, E G Spokes, J Barnes, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|March 1, 1979
Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophreniaA Arregui, A V MacKay, L L Iversen, et al.
Psychological Medicine|May 1, 1980
Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophreniaA Arregui, A V Mackay, E G Spokes, et al.
Clinical Endocrinology|January 1, 1981
Human post-mortem pineal enzyme activityJ A Smith, T J Mee, D J Padwick, et al.
Science (New York, N.Y.)|September 28, 1979
Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatmentN C Bacopoulos, E G Spokes, E D Bird, et al.
Journal of the Neurological Sciences|December 1, 1980
Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjectsE G Spokes, N J Garrett, M N Rossor, et al.
Lancet (London, England)|October 29, 1977
Human post-mortem pineal metabolismJ A Smith, E G Spokes, E D Bird, et al.
European Journal of Clinical Investigation|October 1, 1979
Distribution of beta-endorphin in normal and schizophrenic human brainsS L Lightman, E G Spokes, G A Sagnella, et al.
BMJ (Clinical Research Ed.)|September 15, 1990
Cell implantation in Parkinson's diseaseP Madeley, J L Boyd, C A Biggins, et al.
BMJ (Clinical Research Ed.)|November 30, 1996
Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactionsH H Hamdalla, C H Hawkes, E G Spokes, et al.
Lancet (London, England)|January 21, 1978
Glutamic-acid decarboxylase in schizophreniaE D Bird, E G Spokes, J Barnes, et al.
Pageof 4